Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.76 EUR 0.27% Market Closed
Market Cap: 33.9m EUR
Have any thoughts about
Genoway SA?
Write Note

Intrinsic Value

The intrinsic value of one ALGEN stock under the Base Case scenario is 5.11 EUR. Compared to the current market price of 3.76 EUR, Genoway SA is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALGEN Intrinsic Value
5.11 EUR
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genoway SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALGEN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALGEN?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Genoway SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Genoway SA

Provide an overview of the primary business activities
of Genoway SA.

What unique competitive advantages
does Genoway SA hold over its rivals?

What risks and challenges
does Genoway SA face in the near future?

Has there been any significant insider trading activity
in Genoway SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genoway SA.

Provide P/S
for Genoway SA.

Provide P/E
for Genoway SA.

Provide P/OCF
for Genoway SA.

Provide P/FCFE
for Genoway SA.

Provide P/B
for Genoway SA.

Provide EV/S
for Genoway SA.

Provide EV/GP
for Genoway SA.

Provide EV/EBITDA
for Genoway SA.

Provide EV/EBIT
for Genoway SA.

Provide EV/OCF
for Genoway SA.

Provide EV/FCFF
for Genoway SA.

Provide EV/IC
for Genoway SA.

Show me price targets
for Genoway SA made by professional analysts.

What are the Revenue projections
for Genoway SA?

How accurate were the past Revenue estimates
for Genoway SA?

What are the Net Income projections
for Genoway SA?

How accurate were the past Net Income estimates
for Genoway SA?

What are the EPS projections
for Genoway SA?

How accurate were the past EPS estimates
for Genoway SA?

What are the EBIT projections
for Genoway SA?

How accurate were the past EBIT estimates
for Genoway SA?

Compare the revenue forecasts
for Genoway SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genoway SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genoway SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genoway SA compared to its peers.

Compare the P/E ratios
of Genoway SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Genoway SA with its peers.

Analyze the financial leverage
of Genoway SA compared to its main competitors.

Show all profitability ratios
for Genoway SA.

Provide ROE
for Genoway SA.

Provide ROA
for Genoway SA.

Provide ROIC
for Genoway SA.

Provide ROCE
for Genoway SA.

Provide Gross Margin
for Genoway SA.

Provide Operating Margin
for Genoway SA.

Provide Net Margin
for Genoway SA.

Provide FCF Margin
for Genoway SA.

Show all solvency ratios
for Genoway SA.

Provide D/E Ratio
for Genoway SA.

Provide D/A Ratio
for Genoway SA.

Provide Interest Coverage Ratio
for Genoway SA.

Provide Altman Z-Score Ratio
for Genoway SA.

Provide Quick Ratio
for Genoway SA.

Provide Current Ratio
for Genoway SA.

Provide Cash Ratio
for Genoway SA.

What is the historical Revenue growth
over the last 5 years for Genoway SA?

What is the historical Net Income growth
over the last 5 years for Genoway SA?

What is the current Free Cash Flow
of Genoway SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genoway SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genoway SA

Current Assets 17.3m
Cash & Short-Term Investments 4.9m
Receivables 11m
Other Current Assets 1.4m
Non-Current Assets 14.5m
Long-Term Investments 2.6m
PP&E 6m
Intangibles 5.6m
Other Non-Current Assets 306.4k
Current Liabilities 9m
Accounts Payable 3.6m
Accrued Liabilities 1.8m
Short-Term Debt 7.4k
Other Current Liabilities 3.6m
Non-Current Liabilities 5m
Long-Term Debt 4.7m
Other Non-Current Liabilities 306.4k
Efficiency

Earnings Waterfall
Genoway SA

Revenue
21.4m EUR
Cost of Revenue
-1.6m EUR
Gross Profit
19.8m EUR
Operating Expenses
-18.1m EUR
Operating Income
1.7m EUR
Other Expenses
-476.6k EUR
Net Income
1.3m EUR

Free Cash Flow Analysis
Genoway SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALGEN Profitability Score
Profitability Due Diligence

Genoway SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROE is Increasing
50/100
Profitability
Score

Genoway SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ALGEN Solvency Score
Solvency Due Diligence

Genoway SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
61/100
Solvency
Score

Genoway SA's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALGEN Price Targets Summary
Genoway SA

Wall Street analysts forecast ALGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGEN is 6.73 EUR with a low forecast of 6.67 EUR and a high forecast of 6.93 EUR.

Lowest
Price Target
6.67 EUR
77% Upside
Average
Price Target
6.73 EUR
79% Upside
Highest
Price Target
6.93 EUR
84% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALGEN?

Click here to dive deeper.

Dividends

Genoway SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALGEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALGEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Genoway SA Logo
Genoway SA

Country

France

Industry

Biotechnology

Market Cap

32.5m EUR

Dividend Yield

0%

Description

genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.

Contact

AUVERGNE-RHONE-ALPES
Lyon
Technopark 2, 31 Rue Saint Jean-de-Dieu
+33437654100.0
www.genoway.com

IPO

2007-05-04

Employees

121

Officers

Founder, GM & Director
Dr. Alexandre Fraichard

See Also

Discover More
What is the Intrinsic Value of one ALGEN stock?

The intrinsic value of one ALGEN stock under the Base Case scenario is 5.11 EUR.

Is ALGEN stock undervalued or overvalued?

Compared to the current market price of 3.76 EUR, Genoway SA is Undervalued by 26%.

Back to Top